ドライアイ症候群の世界市場：2025年

ドライアイ症候群の市場規模は今後数年で急成長が見込まれます。CAGR 7.5％で推移し、2029年には56億3,000万米ドルに成長すると予測されています。

予測期間の成長は、人口の高齢化、スクリーン使用の増加、生活習慣の変化、ヘルスケアに対する認識とアクセスのしやすさ、眼科手術の動向、新規治療法の開発などに起因すると考えられています。予測期間の主な動向には、目の健康に対するアプローチ、眼科医療におけるAIの統合、遠隔医療と遠隔診察、個別化医療アプローチ、意識と教育の向上などがあります。

ドライアイ症候群市場の成長は、ドライアイ症候群の有病率の増加によって牽引される見通しです。ドライアイ症候群向けの製品や医薬品は、潤滑油と水分を供給し、涙の分泌を促進し、涙の質を高め、炎症を抑え、眼表面を保護することを目的としています。Eyes On Eyecareが2022年3月に実施した調査によると、2022年には3,500万人の米国人がドライアイ (DED) を経験すると予測されており、今後もその頻度は増加するとされています。さらに、UpToDate Inc.によると、2022年に米国で行われた3つの研究のメタアナリシスでは、ドライアイの潜在的有病率は8.1%と報告されています。これらのことから、ドライアイ症候群の有病率の上昇は市場の重要な促進要因です。

また、高齢者人口の増加もドライアイ症候群市場の成長に寄与しています。世界保健機関 (WHO) は、2030年までに6人に1人が60歳以上になり、この年齢層は2050年までに21億人に倍増すると予測しています。英国では、英国議会下院図書館のデータによると、2043年までに総人口の24％ (1,740万人) が高齢者になると報告されています。これらのことから、高齢者人口の増加もドライアイ症候群市場の原動力となります。

当レポートでは、世界のドライアイ症候群の市場を調査し、市場概要・特徴、主要動向、市場影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 ドライアイ症候群市場：特徴

第3章 ドライアイ症候群市場：動向・戦略

第4章 ドライアイ症候群市場：マクロ経済シナリオ (金利、インフレ、地政学、COVID-19とその回復が市場に与える影響を含む)

第5章 世界のドライアイ症候群市場：成長分析・戦略分析フレームワーク

• PESTEL分析・成長推進因子/阻害因子
• エンドユーザー産業の分析
• 市場成長率の分析
• 市場規模の推移・成長率
• 市場規模の成長予測
• TAM (Total Addressable Market) 市場

第6章 ドライアイ症候群市場：セグメンテーション

• 市場規模の推移・予測：製品別
• 液状点眼剤
• ゲル
• 液体ワイプ
• 眼軟膏
• その他
• 市場規模の推移・予測：治療薬別
• コルチコステロイド
• 人工涙液
• 経口オメガサプリメント
• 潤滑剤
• その他
• 市場規模の推移・予測：疾患タイプ別
• 蒸発亢進型
• 涙液欠乏型
• 市場規模の推移・予測：流通チャネル別
• オフライン
• オンライン
• 市場規模の推移・予測：用途別
• 病院・診療所
• 医療ラボ
• その他
• 市場規模の推移・予測：液状点眼剤のサブタイプ別
• 防腐剤不使用の点眼薬
• 保存液滴
• 抗生物質入り点眼薬
• 市場規模の推移・予測：ジェルのサブタイプ別
• 長持ちジェル
• ハイドロゲル製剤
• 市場規模の推移・予測：液体ワイプのサブタイプ別
• 湿潤ワイプ
• 抗菌ワイプ
• 市場規模の推移・予測：眼軟膏のサブタイプ別
• 夜間用軟膏
• 治療用軟膏
• 市場規模の推移・予測：その他の製品のサブタイプ別
• アイマスク
• コンタクトレンズソリューション
• 栄養補助食品

第7章 ドライアイ症候群市場：地域・国別分析

• 市場規模の推移・予測：地域別
• 市場規模の推移・予測：国別

第8章 アジア太平洋のドライアイ症候群市場

第9章 中国のドライアイ症候群市場

第10章 インドのドライアイ症候群市場

第11章 日本のドライアイ症候群市場

第12章 オーストラリアのドライアイ症候群市場

第13章 インドネシアのドライアイ症候群市場

第14章 韓国のドライアイ症候群市場

第15章 西欧のドライアイ症候群市場

第16章 英国のドライアイ症候群市場

第17章 ドイツのドライアイ症候群市場

第18章 フランスのドライアイ症候群市場

第19章 イタリアのドライアイ症候群市場

第20章 スペインのドライアイ症候群市場

第21章 東欧のドライアイ症候群市場

第22章 ロシアのドライアイ症候群市場

第23章 北米のドライアイ症候群市場

第24章 米国のドライアイ症候群市場

第25章 カナダのドライアイ症候群市場

第26章 南米のドライアイ症候群市場

第27章 ブラジルのドライアイ症候群市場

第28章 中東のドライアイ症候群市場

第29章 アフリカのドライアイ症候群市場

第30章 ドライアイ症候群市場：その他の大手および革新的企業

• 競合情勢
• 企業プロファイル
  • Allergan plc
  • Novartis AG
  • Otsuka Pharmaceutical Co. Ltd.
  • Santendo Pharmaceutical Co. Ltd.
  • Sentiss Pharma Pvt. Ltd.

第31章 ドライアイ症候群市場：その他の大手および革新的企業

• Johnson & Johnson
• Alcon Vision LLC
• Akorn Operating Company LLC
• Sun Pharmaceutical Industries Ltd.
• Bausch Health Companies Inc.
• AbbVie Inc.
• I-MED Pharma Inc.
• AFT Pharmaceuticals
• Horus Pharma
• Mitotech
• Novaliq GmbH
• OASIS Medical
• Prestige Consumer Healthcare
• VISUfarma
• Alimera Science

第32章 世界のドライアイ症候群市場：競合ベンチマーキングとダッシュボード

第33章 ドライアイ症候群市場：主要M&A

第34章 ドライアイ症候群市場：最近の動向

第35章 ドライアイ症候群市場：潜在性の高い国・セグメント・戦略

• 最も新しい機会を提供する国
• 最も新しい機会を提供するセグメント
• 成長戦略

第36章 付録

Dry eye syndrome, also known as dry eye illness, is a prevalent condition characterized by insufficient tear production or the generation of poor-quality tears. The condition manifests when the eyes fail to produce an adequate amount of tears, leading to discomfort, irritation, and inflammation.

Products designed to address dry eye syndrome include liquid drops, gel formulations, liquid wipes, eye ointments, and other related solutions. Liquid eye drops, specifically, are fluid formulations applied directly to the eyes to alleviate dryness, provide moisture, and offer lubrication. These drops encompass a variety of treatments, ranging from corticosteroids to artificial tears, oral omega supplements, and lubricating agents. These products are available through both offline and online channels and are employed in the treatment of evaporative and aqueous diseases. They find application in diverse settings, including hospitals, clinics, medical laboratories, and other healthcare facilities.

The dry eye syndrome market research report is one of a series of new reports from The Business Research Company that provides dry eye syndrome market statistics, including dry eye syndrome industry global market size, regional shares, competitors with a dry eye syndrome market share, detailed dry eye syndrome market segments, market trends, and opportunities, and any further data you may need to thrive in the dry eye syndrome industry. This dry eye syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dry eye syndrome market size has grown strongly in recent years. It will grow from$3.92 billion in 2024 to $4.21 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to healthcare accessibility, evolving treatment options, medications and health conditions, hormonal changes, ocular surgery impact

The dry eye syndrome market size is expected to see strong growth in the next few years. It will grow to $5.63 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to aging population demographics, increasing screen usage, shift in lifestyle habits, healthcare awareness and accessibility, ocular surgery trends, development of novel therapies. Major trends in the forecast period include holistic approach to eye health, integration of ai in eye care, telemedicine and remote consultations, personalized medicine approach, rise in awareness and education.

The anticipated growth of the dry eye syndrome market is expected to be driven by the increasing prevalence of dry eye syndrome. This condition occurs when the eyes do not produce enough tears, and products and medications designed for dry eye syndrome aim to provide lubrication and moisture, boost tear production, enhance tear quality, reduce inflammation, and protect the ocular surface. For instance, a survey conducted by Eyes On Eyecare in March 2022 revealed that 35 million Americans were projected to experience dry eye disease (DED) in 2022, with a continued increase in frequency. Additionally, a meta-analysis of three US studies in 2022, according to UpToDate Inc., reported an 8.1% pooled prevalence of dry eye. Hence, the rising prevalence of dry eye syndrome is a significant driver for the market.

The growth of the dry eye syndrome market is the expanding aging population. This demographic trend, characterized by a rising proportion of elderly individuals, creates an increased demand for effective treatments and solutions for conditions such as dry eye syndrome. Globally, the World Health Organization projects that by 2030, 1 in 6 people will be 60 or older, and this age group will double to 2.1 billion by 2050. In the UK, data from the UK Parliament's House of Commons Library indicates that by 2043, 24% of the total population (17.4 million people) will consist of seniors. Consequently, the growing aging population becomes a driving force for the dry eye syndrome market.

Product innovation stands out as a prominent trend, with major companies focusing on the development of innovative solutions to maintain their market position. For example, in May 2023, Entod Pharmaceuticals Ltd., an India-based company, introduced Cyclotears eye drops, specifically designed for treating dry eye disease. This pioneering product incorporates self-emulsifying drug delivery system (SEDDS) technology, enhancing the delivery of poorly water-soluble drugs to the ocular region. Cyclotears eye drops utilize cyclodextrin to enhance stability and retention time of the tear film on the eye surface. Some highlighted features include a novel active ingredient, improved retention time, a lubricating effect, and being safe and preservative-free.

Major players in the dry eye syndrome market are directing their efforts towards launching innovative products to address the increasing demand for preservative-free eye drops. An example is Systane, with its Systane Complete Preservative-Free Lubricant Eye Drops added to its innovative portfolio of dry eye products. Alcon, a Switzerland-based ophthalmology company, introduced these eye drops in January 2022 to cater to individuals experiencing dry eyes, a condition resulting from insufficient tear production or rapid tear evaporation. Systane Complete Preservative-Free Lubricant Eye Drops aim to alleviate various dry eye symptoms, providing relief, protection, and hydration.

In June 2022, Novartis AG, a Switzerland-based pharmaceutical corporation, completed the acquisition of Kedalion Therapeutics for an undisclosed amount. This strategic move positions Novartis AG to deliver customer- and patient-centric ophthalmic advancements, particularly for dry eye syndrome, and strengthens its leadership in the rapidly growing ophthalmology market. Kedalion Therapeutics, a US-based clinical-stage ophthalmic drug company, offers a range of products and preventive services for dry eye syndrome.

Major companies operating in the dry eye syndrome market include Allergan plc, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Santendo Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., Johnson & Johnson, Alcon Vision LLC, Akorn Operating Company LLC, Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., AbbVie Inc., I-MED Pharma Inc., AFT Pharmaceuticals, Horus Pharma, Mitotech, Novaliq GmbH, OASIS Medical, Prestige Consumer Healthcare, VISUfarma, Alimera Science, Kala Pharmaceuticals Inc., Nicox S.A., EyeGate Pharmaceuticals Inc., ReVision Therapeutics Inc., Itear Medical

North America was the largest region in the dry eye syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global dry eye syndrome market report during the forecast period. The regions covered in the dry eye syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the dry eye syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The dry eye syndrome market includes revenues earned by entities by providing services such as dry eye diagnosis, treatment of dry eye syndrome, prescribed medications, antibiotics, humidifiers, and protective eyewear. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dry Eye Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dry eye syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dry eye syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dry eye syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Liquid Drops; Gel; Liquid Wipes; Eye Ointment; Other Products
• 2) By Treatment: Corticosteroids; Artificial Tears; Oral Omega Supplements; Lubricating Agent; Other Treatments
• 3) By Disease Type: Evaporative; Aqueous
• 4) By Distribution Channel: Offline; Online
• 5) By Application: Hospitals And Clinics; Medical Laboratories; Other Applications
• Subsegments:
• 1) By Liquid Drops: Preservative-Free Drops; Preserved Liquid Drops; Antibiotic-Infused Drops
• 2) By Gel: Long-Lasting Gels; Hydrogel Formulations
• 3) By Liquid Wipes: Pre-Moistened Wipes; Anti-Bacterial Wipes
• 4) By Eye Ointment: Night-Time Ointments; Therapeutic Ointments
• 5) By Other Products: Eye Masks; Contact Lens Solutions; Nutritional Supplements
• Companies Mentioned: Allergan plc; Novartis AG; Otsuka Pharmaceutical Co. Ltd.; Santendo Pharmaceutical Co. Ltd.; Sentiss Pharma Pvt. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dry Eye Syndrome Market Characteristics

3. Dry Eye Syndrome Market Trends And Strategies

4. Dry Eye Syndrome Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Dry Eye Syndrome Growth Analysis And Strategic Analysis Framework

• 5.1. Global Dry Eye Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Dry Eye Syndrome Market Growth Rate Analysis
• 5.4. Global Dry Eye Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Dry Eye Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Dry Eye Syndrome Total Addressable Market (TAM)

6. Dry Eye Syndrome Market Segmentation

• 6.1. Global Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Drops
• Gel
• Liquid Wipes
• Eye Ointment
• Other Products
• 6.2. Global Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Artificial Tears
• Oral Omega Supplements
• Lubricating Agent
• Other Treatments
• 6.3. Global Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Evaporative
• Aqueous
• 6.4. Global Dry Eye Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Offline
• Online
• 6.5. Global Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Medical Laboratories
• Other Applications
• 6.6. Global Dry Eye Syndrome Market, Sub-Segmentation Of Liquid Drops, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preservative-Free Drops
• Preserved Liquid Drops
• Antibiotic-Infused Drops
• 6.7. Global Dry Eye Syndrome Market, Sub-Segmentation Of Gel, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Long-Lasting Gels
• Hydrogel Formulations
• 6.8. Global Dry Eye Syndrome Market, Sub-Segmentation Of Liquid Wipes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Moistened Wipes
• Anti-Bacterial Wipes
• 6.9. Global Dry Eye Syndrome Market, Sub-Segmentation Of Eye Ointment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Night-Time Ointments
• Therapeutic Ointments
• 6.10. Global Dry Eye Syndrome Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Eye Masks
• Contact Lens Solutions
• Nutritional Supplements

7. Dry Eye Syndrome Market Regional And Country Analysis

• 7.1. Global Dry Eye Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Dry Eye Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dry Eye Syndrome Market

• 8.1. Asia-Pacific Dry Eye Syndrome Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dry Eye Syndrome Market

• 9.1. China Dry Eye Syndrome Market Overview
• 9.2. China Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dry Eye Syndrome Market

• 10.1. India Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dry Eye Syndrome Market

• 11.1. Japan Dry Eye Syndrome Market Overview
• 11.2. Japan Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dry Eye Syndrome Market

• 12.1. Australia Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dry Eye Syndrome Market

• 13.1. Indonesia Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dry Eye Syndrome Market

• 14.1. South Korea Dry Eye Syndrome Market Overview
• 14.2. South Korea Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dry Eye Syndrome Market

• 15.1. Western Europe Dry Eye Syndrome Market Overview
• 15.2. Western Europe Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dry Eye Syndrome Market

• 16.1. UK Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dry Eye Syndrome Market

• 17.1. Germany Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dry Eye Syndrome Market

• 18.1. France Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dry Eye Syndrome Market

• 19.1. Italy Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dry Eye Syndrome Market

• 20.1. Spain Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dry Eye Syndrome Market

• 21.1. Eastern Europe Dry Eye Syndrome Market Overview
• 21.2. Eastern Europe Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dry Eye Syndrome Market

• 22.1. Russia Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dry Eye Syndrome Market

• 23.1. North America Dry Eye Syndrome Market Overview
• 23.2. North America Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dry Eye Syndrome Market

• 24.1. USA Dry Eye Syndrome Market Overview
• 24.2. USA Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dry Eye Syndrome Market

• 25.1. Canada Dry Eye Syndrome Market Overview
• 25.2. Canada Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dry Eye Syndrome Market

• 26.1. South America Dry Eye Syndrome Market Overview
• 26.2. South America Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dry Eye Syndrome Market

• 27.1. Brazil Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dry Eye Syndrome Market

• 28.1. Middle East Dry Eye Syndrome Market Overview
• 28.2. Middle East Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dry Eye Syndrome Market

• 29.1. Africa Dry Eye Syndrome Market Overview
• 29.2. Africa Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dry Eye Syndrome Market Competitive Landscape And Company Profiles

• 30.1. Dry Eye Syndrome Market Competitive Landscape
• 30.2. Dry Eye Syndrome Market Company Profiles
  • 30.2.1. Allergan plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Santendo Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sentiss Pharma Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Dry Eye Syndrome Market Other Major And Innovative Companies

• 31.1. Johnson & Johnson
• 31.2. Alcon Vision LLC
• 31.3. Akorn Operating Company LLC
• 31.4. Sun Pharmaceutical Industries Ltd.
• 31.5. Bausch Health Companies Inc.
• 31.6. AbbVie Inc.
• 31.7. I-MED Pharma Inc.
• 31.8. AFT Pharmaceuticals
• 31.9. Horus Pharma
• 31.10. Mitotech
• 31.11. Novaliq GmbH
• 31.12. OASIS Medical
• 31.13. Prestige Consumer Healthcare
• 31.14. VISUfarma
• 31.15. Alimera Science

32. Global Dry Eye Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dry Eye Syndrome Market

34. Recent Developments In The Dry Eye Syndrome Market

35. Dry Eye Syndrome Market High Potential Countries, Segments and Strategies

• 35.1 Dry Eye Syndrome Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Dry Eye Syndrome Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Dry Eye Syndrome Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer